{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:49:08Z","timestamp":1794106148256,"version":"4.8.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,4,15]]},"DOI":"10.2169\/internalmedicine.5689-25","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T22:08:20Z","timestamp":1758146900000},"page":"1115-1119","source":"Crossref","is-referenced-by-count":1,"title":["Alterations of the Cytokines, Chemokines, and Growth Factors in the Cerebrospinal Fluid of Patients with Advanced-stage Amyotrophic Lateral Sclerosis"],"prefix":"10.2169","volume":"65","author":[{"given":"Yuka","family":"Machino","sequence":"first","affiliation":[{"name":"Department of Neurology, National Hospital Organization Mie Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Niwa","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Mie Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Tomimoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mie University Graduate School of Medicine, Japan"},{"name":"Department of Neurology, Saiseikai Meiwa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Shindo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 377: 162-172, 2017.","DOI":"10.1056\/NEJMra1603471"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mimic S, Aru B, Pehlivano\u011flu C, Sleiman H, Andjus PR, Yan\u0131kkaya Demirel GY. Immunology of amyotrophic lateral sclerosis - role of the innate and adaptive immunity. Front Neurosci 17: 1277399, 2023.","DOI":"10.3389\/fnins.2023.1277399"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sekizawa T, Openshaw H, Ohbo K, Sugamura K, Itoyama Y, Niland JC. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J Neurol Sci 154: 194-199, 1998.","DOI":"10.1016\/S0022-510X(97)00228-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wilms H, Sievers J, Dengler R, Bufler J, Deuschl G, Lucius R. Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J Neuroimmunol 144: 139-142, 2003.","DOI":"10.1016\/j.jneuroim.2003.08.042"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Moreau C, Devos D, Brunaud-Danel V, et al. Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology 65: 1958-1960, 2005.","DOI":"10.1212\/01.wnl.0000188907.97339.76"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tanaka M, Kikuchi H, Ishizu T, et al. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 65: 816-825, 2006.","DOI":"10.1097\/01.jnen.0000232025.84238.e1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kuhle J, Lindberg RLP, Regeniter A, et al. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol 16: 771-774, 2009.","DOI":"10.1111\/j.1468-1331.2009.02560.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mitchell RM, Freeman WM, Randazzo WT, et al. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 72: 14-19, 2009.","DOI":"10.1212\/01.wnl.0000333251.36681.a5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rentzos M, Rombos A, Nikolaou C, et al. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur Neurol 63: 285-290, 2010.","DOI":"10.1159\/000287582"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tateishi T, Yamasaki R, Tanaka M, et al. CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J Neuroimmunol 222: 76-81, 2010.","DOI":"10.1016\/j.jneuroim.2010.03.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Guo J, Yang X, Gao L, Zang D. Evaluating the levels of CSF and serum factors in ALS. Brain Behav 7: e00637, 2017.","DOI":"10.1002\/brb3.637"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Huang F, Zhu Y, Hsiao-Nakamoto J, et al. Longitudinal biomarkers in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 7: 1103-1116, 2020.","DOI":"10.1002\/acn3.51078"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lu CH, Allen K, Oei F, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflam 3: e244, 2016.","DOI":"10.1212\/NXI.0000000000000244"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates Assessment of Respiratory Function. BDNF Als Study Group (Phase III). J Neurol Sci 169: 13-21, 1999.","DOI":"10.1016\/S0022-510X(99)00210-5"},{"key":"15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2249.2000.01281.x","volume":"121","author":"H Bruunsgaard","year":"2000","unstructured":"15. Bruunsgaard H, Skinh\u00f8j P, Pedersen AN, Schroll M, Pedersen BK. Ageing, tumour necrosis factor-alpha (TNF-\u03b1) and atherosclerosis. Clin Exp Immunol 121: 255-260, 2000.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhou J, Liu B, Liang C, Li Y, Song YH. Cytokine signaling in skeletal muscle wasting. Trends Endocrinol Metab 27: 335-347, 2016.","DOI":"10.1016\/j.tem.2016.03.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ram\u00edrez-V\u00e9lez R, S\u00e1ez De, Asteasu ML, et al. Circulating cytokines and lower body muscle performance in older adults at hospital admission. Nutr Health Aging 24: 1131-1139, 2020.","DOI":"10.1007\/s12603-020-1480-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Dreher M, Schulte L, M\u00fcller T, Ekkernkamp E, Zirlik A. Influence of effective noninvasive positive pressure ventilation on inflammatory and cardiovascular biomarkers in stable hypercapnic COPD patients. Respir Med 109: 1300-1304, 2015.","DOI":"10.1016\/j.rmed.2015.08.004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang BC, Lion RP, Avesar M, Abdala J, Deming DD, Wilson CG. Comparison of local and systemic Inflammation during invasive versus noninvasive ventilation in rats. J Interferon Cytokine Res 42: 343-348, 2022.","DOI":"10.1089\/jir.2022.0040"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nagashima H, Morio Y, Yamane K, Nanjo Y, Teshima R. Tumor necrosis factor-\u03b1, interleukin-1\u03b2, and interleukin-6 in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy. Eur Spine J 18: 1946-1950, 2009.","DOI":"10.1007\/s00586-009-1069-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Krock E, Millecamps M, Anderson KM, et al. Interleukin-8 as a therapeutic target for chronic low back pain: upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse model. EBioMedicine 43: 487-500, 2019.","DOI":"10.1016\/j.ebiom.2019.04.032"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/8\/65_5689-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:50:49Z","timestamp":1776484249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/8\/65_5689-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5689-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"5689-25"}}